Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis
Crossref DOI link: https://doi.org/10.3803/EnM.2020.818
Published Print: 2021-04-30
Update policy: https://doi.org/10.3803/crossmark_policy
Dutta, Deep https://orcid.org/0000-0003-4915-8805
Agarwal, Anshita
Maisnam, Indira
Singla, Rajiv
Khandelwal, Deepak
Sharma, Meha
Text and Data Mining valid from 2021-04-06
Publication History
Received: 2020-08-16
Accepted: 2021-02-15
Published online: 2021-04-06
Print publication: 2021-04-30
